JP2008539167A - 紫外線保護 - Google Patents

紫外線保護 Download PDF

Info

Publication number
JP2008539167A
JP2008539167A JP2008506946A JP2008506946A JP2008539167A JP 2008539167 A JP2008539167 A JP 2008539167A JP 2008506946 A JP2008506946 A JP 2008506946A JP 2008506946 A JP2008506946 A JP 2008506946A JP 2008539167 A JP2008539167 A JP 2008539167A
Authority
JP
Japan
Prior art keywords
branched
compound
formula
group
ethylhexyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008506946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008539167A5 (enExample
Inventor
トマス ルドルフ、
ヘルビック ブーフホルツ、
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005018184A external-priority patent/DE102005018184A1/de
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JP2008539167A publication Critical patent/JP2008539167A/ja
Publication of JP2008539167A5 publication Critical patent/JP2008539167A5/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/893—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Materials Engineering (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
JP2008506946A 2005-04-19 2006-03-21 紫外線保護 Ceased JP2008539167A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005018184A DE102005018184A1 (de) 2005-04-19 2005-04-19 Antioxidantien
EP05025917 2005-11-28
PCT/EP2006/002593 WO2006111234A1 (de) 2005-04-19 2006-03-21 Uv schutz

Publications (2)

Publication Number Publication Date
JP2008539167A true JP2008539167A (ja) 2008-11-13
JP2008539167A5 JP2008539167A5 (enExample) 2012-03-29

Family

ID=36698689

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008506945A Active JP5415755B2 (ja) 2005-04-19 2006-03-21 酸化防止剤
JP2008506946A Ceased JP2008539167A (ja) 2005-04-19 2006-03-21 紫外線保護

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008506945A Active JP5415755B2 (ja) 2005-04-19 2006-03-21 酸化防止剤

Country Status (6)

Country Link
US (2) US8106233B2 (enExample)
EP (2) EP1871339A1 (enExample)
JP (2) JP5415755B2 (enExample)
CN (2) CN101163659B (enExample)
ES (1) ES2568516T3 (enExample)
WO (2) WO2006111234A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538381A (ja) * 2005-04-19 2008-10-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 酸化防止剤
JP2021521183A (ja) * 2018-04-13 2021-08-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 化学的に誘発されたストレスから皮膚を保護するための特定のベンジリデンマロナートの使用

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7058874B2 (en) * 2002-05-24 2006-06-06 Lucent Technologies Inc. Interleaver address generator and method of generating an interleaver address
DE102007005186A1 (de) 2007-01-29 2008-07-31 Merck Patent Gmbh Partikuläres UV-Schutzmittel
DE102007013366A1 (de) 2007-03-16 2008-09-18 Merck Patent Gmbh Verwendung von Chroman-4-on-Derivaten
WO2008119428A1 (en) * 2007-04-03 2008-10-09 Merck Patent Gmbh Photostable compositions
DE102007038098A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
CA2711270C (en) * 2008-01-25 2017-02-28 Schering-Plough Healthcare Products, Inc. Method of selecting antioxidants for use in topically applied compositions
FR2928370B1 (fr) * 2008-03-07 2017-07-14 Catalys Preparation de composes hydroquinone-amide a proprietes anti-oxydantes
JP2010248150A (ja) * 2009-04-17 2010-11-04 Rohto Pharmaceut Co Ltd アドバンスド・グリケーション・エンド・プロダクツの蓄積による肌老化の予防、抑制、又は改善剤
WO2011006566A2 (de) 2009-07-14 2011-01-20 Merck Patent Gmbh Monomethoxy-hydroxy-benzylmalonate
KR20110012148A (ko) * 2009-07-30 2011-02-09 서울대학교산학협력단 펩타이드가 결합된 하이드록시 시나믹산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
WO2011023287A1 (en) 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology
DE102010001905A1 (de) * 2010-02-12 2011-08-18 ROVI Cosmetics International GmbH, 36381 UV-Schutzmittel für die Haut oder die Haare mit einer in einem vesikulären Trägersystem verkapselten UV-Filtersubstanz
DE102010045890A1 (de) 2010-09-17 2012-03-22 Merck Patent Gmbh 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
DE102010051689A1 (de) 2010-11-17 2012-05-24 Merck Patent Gmbh Dihydroxyfumarsäure-Derivate und deren Verwendung zur Hautaufhellung
DE102011102824A1 (de) 2011-05-30 2012-12-06 Merck Patent Gmbh Extrakte aus Eugenia uniflora
DE102011117364A1 (de) 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
CN103385516A (zh) * 2013-07-29 2013-11-13 安徽燕之坊食品有限公司 一种液体补充物
EP4276089A3 (en) 2016-03-03 2023-12-20 Universite De Moncton Modulators of lipoxygenase and cyclooxygenase enzyme activity
US20180221426A1 (en) * 2017-02-06 2018-08-09 William Van Dover Stoecker Compositions and Methods for Treating and Removing Seborrheic Keratoses
JP7132935B2 (ja) 2017-03-06 2022-09-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 適合溶質の使用
CN107157788A (zh) * 2017-05-05 2017-09-15 海南京润珍珠生物技术股份有限公司 一种添加甲氧基肉桂酸乙基己酯脂质体包裹物的防晒霜
CN109010101A (zh) * 2018-09-17 2018-12-18 天津大学 一种广谱化学防晒剂和广谱防晒霜及其制备方法
JP2022543068A (ja) 2019-08-01 2022-10-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 角質化障害の予防および低減、ならびに関連する化粧品剤
CN111603396B (zh) * 2020-06-12 2021-07-20 四川大学 一种聚天然多酚型防晒凝胶及其制备方法
US11547645B2 (en) * 2021-01-05 2023-01-10 L'oreal Organic UVA filter-stabilized antioxidant composition
CN115819239B (zh) * 2021-09-17 2025-11-18 无锡和誉生物医药科技有限公司 一种成纤维细胞生长因子受体抑制剂的中间体及其制备方法和用途

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4910664B1 (enExample) * 1969-07-21 1974-03-12
US4069340A (en) * 1976-01-30 1978-01-17 Hooker Chemicals & Plastics Corporation Immonium salts and derivatives thereof
JPS57123109A (en) * 1980-12-13 1982-07-31 Henkel Kgaa Local cosmetic medicine for treating highly greasy hair and seborrheic skin
JPH03503529A (ja) * 1988-04-01 1991-08-08 ベーリンガー・マンハイム・イタリア・ソチエタ・ペル・アチオニ 白金（２）錯体、その製造法および抗腫瘍剤としての利用
JPH05132433A (ja) * 1991-04-30 1993-05-28 Tsumura & Co 多環性化合物の製造法
JPH05294821A (ja) * 1991-07-17 1993-11-09 L'oreal Sa （２，５−ジヒドロキシフェニル）カルボン酸誘導体、それらの同族体又は塩を有効成分として含有する、脱色作用のある皮膚用又は化粧料組成物
JP2001261654A (ja) * 2000-03-21 2001-09-26 Mitsui Chemicals Inc キノリン誘導体およびそれを有効成分として含有する核内レセプター作動薬
JP2002533299A (ja) * 1998-09-25 2002-10-08 ザ ユニバーシティ オブ クイーンズランド 環状ペプチドの合成
WO2003059864A2 (en) * 2002-01-15 2003-07-24 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
JP2004307460A (ja) * 2002-07-22 2004-11-04 Sankyo Co Ltd マロン酸誘導体
JP2008538381A (ja) * 2005-04-19 2008-10-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 酸化防止剤

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2415624A (en) * 1945-01-17 1947-02-11 Eastman Kodak Co Light-sensitive layers having ultraviolet light filters
US3830828A (en) * 1967-08-17 1974-08-20 Ciba Geigy Corp Stabilizer for organic compounds
US3856911A (en) 1969-07-21 1974-12-24 Takeda Chemical Industries Ltd Cholagogic composition containing pentanedione derivatives
DE2240609A1 (de) * 1972-08-18 1974-02-28 Hoechst Ag Stoffwechselwirksame derivate der 4-hydroxy-3,5-di-alkylphenyl-propionsaeure
EP0100651A1 (en) * 1982-08-03 1984-02-15 VAN DYK & COMPANY, INC. Dialkyl malonates as organic suncreen adjuvants
DE3521558A1 (de) * 1985-06-15 1986-12-18 Basf Ag, 6700 Ludwigshafen 3-t-butyl-4-hydroxiphenylpropionsaeureaminoalkylamidderivate und damit stabilisiertes organisches material
DE3673113D1 (de) * 1985-10-11 1990-09-06 Ciba Geigy Ag Substituierte p-hydroxyphenylverbindungen.
JPS63227542A (ja) * 1987-03-17 1988-09-21 Yoshitomi Pharmaceut Ind Ltd ４−ヒドロキシフエニルプロピオン酸化合物またはそのエステルの製法
JP2552297B2 (ja) 1987-07-03 1996-11-06 ポーラ化成工業株式会社 美肌化粧料
US4888444A (en) * 1987-10-26 1989-12-19 Ciba-Geigy Corporation Substituted hydroxylamine ester stabilizers
US5051531A (en) * 1988-05-31 1991-09-24 Atochem North America, Inc. Antioxidant-peroxides
LU87271A1 (fr) * 1988-07-08 1990-02-07 Oreal Nouveaux derives insatures liposolubles des benzalmalonates et leur utilisation en tant qu'absorbeurs du rayonnement ultra-violet en cosmetique
FR2636338B1 (fr) * 1988-09-09 1990-11-23 Rhone Poulenc Chimie Diorganopolysiloxane a fonction benzalmalonate
DD288830A5 (de) * 1988-10-25 1991-04-11 Ciba-Geigy Ag,Ch Zusammensetzungen und deren verwendung
EP0474589A1 (de) * 1990-08-02 1992-03-11 Ciba-Geigy Ag Orthophenolacetamide
CA2067552A1 (en) 1991-04-30 1992-10-31 Masahide Tanaka Process for the preparation of polycyclic compounds
US5453514A (en) * 1992-12-25 1995-09-26 Yamanouchi Pharmaceutical Co., Ltd. Pyrazole derivatives and compositions and methods of use as maillard reaction inhibitors
PL183812B1 (pl) * 1996-12-17 2002-07-31 Politechnika Wroclawska Nowe chlorki alkoksymetyloamoniowe pochodne aminoestrów kwasu p-(3,5-di-t-butylo-4-hydroksy)- fenylopropionowego
BE1014162A3 (fr) * 1997-05-26 2003-06-03 Ciba Sc Holding Ag Produits stabilisants, compositions et concentres les contenant, et leur procede d'utilisation.
US5834544A (en) * 1997-10-20 1998-11-10 Uniroyal Chemical Company, Inc. Organic materials stabilized by compounds containing both amine and hindered phenol functional functionalities
EP1169292B1 (en) 1999-03-26 2004-11-24 Firmenich S.A. Cyclic compounds and their use as precursors of fragrant alcohols
DE10000209A1 (de) * 2000-01-05 2001-07-12 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
PL196298B1 (pl) * 2000-02-29 2007-12-31 Politechnika Wroclawska Nowe sole dietyloamoniowe pochodne aminoestru kwasu b-(3,5-di-t-butylo-4-hydroksy)fenylopropionowego
DE10124914A1 (de) 2001-05-22 2002-11-28 Henkel Kgaa Lipoprotein-Cremes mit UV-Filtern
JP4463549B2 (ja) 2001-07-16 2010-05-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸化防止特性を有する光安定性の有機日焼け止め化合物およびそれから得られる組成物
EP1604643A1 (en) 2004-06-03 2005-12-14 Cognis France, S.A.S. Cosmetic use of derivatives of 3-Phenylpropionic acid

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4910664B1 (enExample) * 1969-07-21 1974-03-12
US4069340A (en) * 1976-01-30 1978-01-17 Hooker Chemicals & Plastics Corporation Immonium salts and derivatives thereof
JPS57123109A (en) * 1980-12-13 1982-07-31 Henkel Kgaa Local cosmetic medicine for treating highly greasy hair and seborrheic skin
JPH03503529A (ja) * 1988-04-01 1991-08-08 ベーリンガー・マンハイム・イタリア・ソチエタ・ペル・アチオニ 白金（２）錯体、その製造法および抗腫瘍剤としての利用
JPH05132433A (ja) * 1991-04-30 1993-05-28 Tsumura & Co 多環性化合物の製造法
JPH05294821A (ja) * 1991-07-17 1993-11-09 L'oreal Sa （２，５−ジヒドロキシフェニル）カルボン酸誘導体、それらの同族体又は塩を有効成分として含有する、脱色作用のある皮膚用又は化粧料組成物
JP2002533299A (ja) * 1998-09-25 2002-10-08 ザ ユニバーシティ オブ クイーンズランド 環状ペプチドの合成
JP2001261654A (ja) * 2000-03-21 2001-09-26 Mitsui Chemicals Inc キノリン誘導体およびそれを有効成分として含有する核内レセプター作動薬
WO2003059864A2 (en) * 2002-01-15 2003-07-24 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
JP2004307460A (ja) * 2002-07-22 2004-11-04 Sankyo Co Ltd マロン酸誘導体
JP2008538381A (ja) * 2005-04-19 2008-10-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 酸化防止剤

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
BEY,P., TETRAHEDRON LETTERS, vol. V19 N52, JPN5008004525, 1978, pages 5225 - 5228, ISSN: 0002058028 *
CHRAIBI,A., ANNALES PHARMACEUTIQUES FRANCAISES, vol. V38 N4, JPN5008004523, 1980, pages 343 - 352, ISSN: 0002058033 *
CHUANG,C-P, TETRAHEDRON, vol. V54 N34, JPN5008004515, 20 August 1998 (1998-08-20), NL, pages 10043 - 10052, ISSN: 0002058023 *
COOK,J.W., J.CHEM.SOC., JPN5008004518, 1944, pages 322 - 325, ISSN: 0002058024 *
DEAN,F.M., J.CHEM.SOC., JPN5008004527, 1950, pages 895 - 902, ISSN: 0002058035 *
DIANA,G.D., J.MED.CHEM., vol. V21 N9, JPN5008004517, 1978, pages 889 - 894, ISSN: 0002058030 *
HEY,D.H., J.CHEM.SOC., JPN5008004524, 1953, pages 1894 - 1899, ISSN: 0002058027 *
IRIE,H., CHEMISTRY LETTERS, vol. N7, JPN5008004514, 1 July 1980 (1980-07-01), JP, pages 875 - 878, ISSN: 0002058021 *
JEW,SANG-SUP, HETEROCYCLES, vol. V46, JPN5008004520, 1997, pages 65 - 70, ISSN: 0002058026 *
KIRKIACHARIAN,B.SERGE, COMPTES RENDUS DES SEANCES DE L'ACADEMIE DES SCIENCES,SERIE 2, vol. V294 N3, JPN5008004521, 1982, pages 181 - 184, ISSN: 0002058031 *
KUJUNDZIC,N., CROATICA CHEMICA ACTA, vol. V61 N1, JPN5008004519, 1988, pages 121 - 135, ISSN: 0002058025 *
RARE CHEMICALS CATALOGUE, JPN5008004528, 27 September 2004 (2004-09-27), DE, ISSN: 0002058029 *
RUSSELL,P.B., J.AM.CHEM.SOC., vol. V74 N13, JPN5008004516, 5 July 1952 (1952-07-05), pages 3443 - 3444, ISSN: 0002058022 *
SOHDA,T., CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. V31 N2, JPN5008004522, February 1983 (1983-02-01), JP, pages 560 - 569, ISSN: 0002058032 *
WESTFAHL,J.C., J.AM.CHEM.SOC., vol. V76 N4, JPN5008004526, 20 February 1954 (1954-02-20), pages 1076 - 1080, ISSN: 0002058034 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008538381A (ja) * 2005-04-19 2008-10-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 酸化防止剤
JP2021521183A (ja) * 2018-04-13 2021-08-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 化学的に誘発されたストレスから皮膚を保護するための特定のベンジリデンマロナートの使用
JP7390306B2 (ja) 2018-04-13 2023-12-01 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 化学的に誘発されたストレスから皮膚を保護するための特定のベンジリデンマロナートの使用

Also Published As

Publication number Publication date
CN101163659B (zh) 2012-09-05
JP5415755B2 (ja) 2014-02-12
CN101163659A (zh) 2008-04-16
ES2568516T3 (es) 2016-04-29
US8106233B2 (en) 2012-01-31
EP1871339A1 (de) 2008-01-02
US8268293B2 (en) 2012-09-18
WO2006111234A1 (de) 2006-10-26
EP1871735A1 (de) 2008-01-02
EP1871735B1 (de) 2015-12-23
WO2006111233A1 (de) 2006-10-26
US20080171004A1 (en) 2008-07-17
JP2008538381A (ja) 2008-10-23
CN101203278A (zh) 2008-06-18
US20080152603A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
JP5415755B2 (ja) 酸化防止剤
JP5292281B2 (ja) 酸化防止剤
JP2008539167A5 (enExample)
JP4850397B2 (ja) クロメン−４−オン誘導体類の使用
US20040067894A1 (en) Preparation having antioxidant properties
JP6099691B2 (ja) 化粧品としてのインドール化合物の使用
US20030060426A1 (en) Formulation for protection against oxidative stress containing benzofuranone derivatives
US20040091433A1 (en) Light-protection agents
JP2005132842A (ja) 抗酸化特性を有する組成物
US20090220438A1 (en) Chromen-4-one derivatives as self-tanning substance
US20080038213A1 (en) Uv Filters
JP2008509173A (ja) フラボノイド複合体
US8052963B2 (en) [(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives
US20090098072A1 (en) Antioxidants
US20060292093A1 (en) Chromen-4-one derivatives
US7867993B2 (en) Preparation containing oxidized flavonoid derivatives
WO2009021590A1 (de) Tyrosinaseinhibitoren

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090317

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090317

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120201

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120201

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121204

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20130423